Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anemia and single-lineage marrow failure: a pilot study and a survey from EBMT WPSAA. [PDF]
Bacigalupo A +14 more
core
Epidemiologic sequential analysis of pure red blood cell aplasia and T-cell large granular lymphocyte leukemia in Korea. [PDF]
Park S, Kim HK.
europepmc +1 more source
Non-traditional cardiovascular risk factors after kidney transplantation. [PDF]
Belal AA, Santos AH, Kazory A.
europepmc +1 more source
Early-onset neutropenia and mixed phenotype in ADA2 deficiency: diagnostic and therapeutic challenges. [PDF]
Kaplan Sarıkavak S +6 more
europepmc +1 more source
Immune-mediated pure red cell aplasia in renal transplant recipients
Julien Zuber +5 more
doaj +1 more source
Pure red-cell aplasia after radioactive iodine treatment in a patient with papillary thyroid cancer and follow up for two years: a case report. [PDF]
Li R, Wang M, Li S, Liao L.
europepmc +1 more source
Large granular lymphocyte cells and immune dysregulation diseases – The chicken or the egg? [PDF]
Assmann, J.L.J.C. (Jorn L. J. C.) +1 more
core +3 more sources
Pure red cell aplasia and amegakaryocytic thrombocytopenia in a cat. [PDF]
Suwa A.
europepmc +1 more source
Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature [PDF]
core +1 more source
Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory/relapsed pure red cell aplasia: a prospective clinical study. [PDF]
Zhang L +9 more
europepmc +1 more source

